Finance

Lists
0A9W:LON
Organon & Co
13,77 $
+0,07%
(+0,010) 1D
16 қаз., 19:05:06 GMT+1  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for 0A9W...
Open
13,76 $
High
13,78 $
Low
13,76 $
Mkt. cap
3,61 млрд
Avg. vol.
3,86 мың
Volume
65,00
52-wk high
13,78 $
52-wk low
9,19 $
No. of employees
10 мың
Open
13,76 $
High
13,78 $
Low
13,76 $
Mkt. cap
3,61 млрд
Avg. vol.
3,86 мың
Volume
65,00
52-wk high
13,78 $
52-wk low
9,19 $
No. of employees
10 мың
News stories
From web sources and news partners
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 мың
Founded1923
HeadquartersДжерсей Сити, Нью-Джерси, Америка Құрама Штаттары
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,60 млрд
1,51 млрд
1,46 млрд
1,56 млрд
Cost of goods sold
733,00 млн
741,00 млн
670,00 млн
711,00 млн
Cost of revenue
733,00 млн
741,00 млн
670,00 млн
711,00 млн
Research and development expenses
84,00 млн
91,00 млн
93,00 млн
90,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
415,00 млн
431,00 млн
424,00 млн
434,00 млн
Operating expense
499,00 млн
522,00 млн
517,00 млн
524,00 млн
Total operating expenses
1,23 млрд
1,26 млрд
1,19 млрд
1,24 млрд
Operating income
370,00 млн
244,00 млн
273,00 млн
323,00 млн
Other non operating income
30,00 млн
-18,00 млн
15,00 млн
-3,00 млн
EBT including unusual items
243,00 млн
-148,00 млн
213,00 млн
183,00 млн
EBT excluding unusual items
255,00 млн
103,00 млн
170,00 млн
210,00 млн
Income tax expense
83,00 млн
57,00 млн
67,00 млн
75,00 млн
Effective tax rate
34,16%
-38,51%
31,46%
40,98%
Other operating expenses
-
-
-
-
Net income
160,00 млн
-205,00 млн
146,00 млн
108,00 млн
Net profit margin
9,99%
-13,60%
10,00%
6,93%
Earnings per share
1,01
0,63
0,71
0,85
Interest and investment income
-
-
-
-
Interest expense
-128,00 млн
-121,00 млн
-111,00 млн
-108,00 млн
Net interest expenses
-128,00 млн
-121,00 млн
-111,00 млн
-108,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
462,00 млн
340,00 млн
359,00 млн
403,00 млн
Gain or loss from assets sale
-
-
-81,00 млн
-
AI content may include mistakes. Learn more
Google қолданбалары